ForSight Robotics Raises $55M Series A to Revolutionize Cataract Surgery with ORYOM Robotic Platform

ForSight Robotics is thrilled to announce that it has secured $55,000,000 in its latest funding round—a major milestone in our journey to redefine quality surgical eye care. This remarkable achievement reinforces our commitment to revolutionizing global healthcare through advanced medical technology. At the heart of our innovation is ORYOM, the first robotic surgery platform designed specifically for cataracts and widespread eye diseases. By integrating cutting-edge computer vision, AI-driven machine learning, and precision microsurgical robotics, we are equipping eye surgeons around the globe with the tools they need to turn science fiction into measurable, life-changing realities. The funds raised will accelerate the development and deployment of ORYOM, allowing us not only to enhance our existing technology but also to expand our reach into new markets where quality eye care remains elusive. As we push the boundaries of what's possible in surgical precision and patient outcomes, our investment in research and development will also support initiatives to train surgeons in the efficient use of ORYOM, ensuring that clinical advancements translate into improved patient experiences worldwide. Founded in 2020 by pioneering minds in surgical robotics, ForSight Robotics has always been driven by the vision of democratizing quality surgical eye care and restoring sight to millions. This new injection of capital represents a vote of confidence in our mission and the transformative impact of our technology. We invite innovators, healthcare professionals, and visionary investors to follow our journey and join us in reshaping the future of eye surgery. Explore our open positions and become a part of the revolution at https://www.linkedin.com/company/forsightrobotics/jobs/.